Lactobacillus acidophilus Supplementation Exerts a Synergistic Effect on Tacrolimus Efficacy by Modulating Th17/Treg Balance in Lupus-Prone Mice via the SIGNR3 Pathway
ObjectiveTacrolimus (Tac) is an immunosuppressant used in the treatment of systemic lupus erythematosus (SLE); however, it induces T cell subset imbalances by reducing regulatory T (Treg) cells. Lactobacillus acidophilus (LA) is reported to have therapeutic efficacy in immune-mediated diseases via T...
Main Authors: | Da Som Kim, Youngjae Park, Jeong-Won Choi, Sung-Hwan Park, Mi-La Cho, Seung-Ki Kwok |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.696074/full |
Similar Items
-
LO-013 Novel pathogenetic mechanisms mediated by dysregulation of TRIM21-STING-type I interferon axis in lupus
by: Seung-Ki Kwok, et al.
Published: (2023-07-01) -
LP-094 Repression of Id3 aggravates lupus phenotypes in murine models via aberrant B cell differentiation
by: Seung-Ki Kwok, et al.
Published: (2023-07-01) -
Lactobacillus acidophilus and propionate attenuate Sjögren’s syndrome by modulating the STIM1-STING signaling pathway
by: Jin Seok Woo, et al.
Published: (2023-06-01) -
Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance
by: Soon Kyu Lee, et al.
Published: (2021-01-01) -
Induction of liver transplant immune tolerance in an outbred rat strain model using tacrolimus
by: Min-Jung Park, et al.
Published: (2023-03-01)